<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38813984</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2150-1327</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Journal of primary care &amp; community health</Title><ISOAbbreviation>J Prim Care Community Health</ISOAbbreviation></Journal><ArticleTitle>Longitudinal Progression of Patients with Long COVID Treated in a Post-COVID Clinic: A Cross-Sectional Survey.</ArticleTitle><Pagination><StartPage>21501319241258671</StartPage><MedlinePgn>21501319241258671</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">21501319241258671</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/21501319241258671</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">In addition to the morbidity and mortality associated with acute infection, COVID-19 has been associated with persistent symptoms (&gt;30&#x2009;days), often referred to as Long COVID (LC). LC symptoms often cluster into phenotypes, resembling conditions such as fibromyalgia, postural orthostatic tachycardiac syndrome (POTS), and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). LC clinics have been established to best address the needs of LC patients and continuity of care. We developed a cross-sectional survey to assess treatment response through our LC Clinic (LCC).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A 25-question survey (1-10 Likert scale) was expert- and content-validated by LCC clinicians, patients, and patient advocates. The survey assessed LC symptoms and the helpfulness of different interventions, including medications and supplements. A total of 852 LCC patients were asked to complete the survey, with 536 (62.9%) responding.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The mean time from associated COVID-19 infection to survey completion was 23.2&#x2009;&#xb1;&#x2009;6.4&#x2009;months. The mean age of responders was 52.3&#x2009;&#xb1;&#x2009;14.1 (63% females). Self-reported symptoms were all significantly improved (<i>P</i>&#x2009;&lt;&#x2009;.001) from the initial visit to the LCC (baseline) to the time of the follow-up survey. However, only 4.5% (24/536) of patients rated all symptoms low (1-2) at the time of the survey, indicating low levels of full recovery in our cohort. The patients rated numerous interventions as being helpful, including low-dose naltrexone (45/77; 58%), vagal nerve stimulation (18/34; 53%), and fisetin (28/44; 64%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Patients report general improvements in symptoms following the initial LCC visit, but complete recovery rates remain low at 23.2&#x2009;&#xb1;&#x2009;6.4&#x2009;months.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hurt</LastName><ForeName>Ryan T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Siddhant</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Darrell R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croghan</LastName><ForeName>Ivana T</ForeName><Initials>IT</Initials><Identifier Source="ORCID">0000-0003-3464-3525</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grach</LastName><ForeName>Stephanie L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-8337-6219</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aakre</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilman</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overgaard</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Nerissa M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawson</LastName><ForeName>Donna K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Ann M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natividad</LastName><ForeName>Lasonya T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed Elfadil</LastName><ForeName>Osman</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesh</LastName><ForeName>Ravindra</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6877-1712</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Prim Care Community Health</MedlineTA><NlmUniqueID>101518419</NlmUniqueID><ISSNLinking>2150-1319</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ME-CFS</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomeylitis</Keyword><Keyword MajorTopicYN="N">orthostatic tachycardiac syndrome</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: RTH is a consultant for Nestle Nutrition. All authors declare no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3&#x2009;years; and no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>30</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>30</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>30</Day><Hour>8</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38813984</ArticleId><ArticleId IdType="pmc">PMC11141226</ArticleId><ArticleId IdType="doi">10.1177/21501319241258671</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al.. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AM, Brigham E, Connolly B, et al.. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9:1328-1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall A, Brito-Zeron P, Conangla Ferrin L, et al.. Long covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18:4350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Ghosh AK, Nyman MA, et al.. PROMIS scales for assessment of persistent post-COVID symptoms: a cross sectional study. J Prim Care Community Health. 2021;12:21501327211030413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267017</ArticleId><ArticleId IdType="pubmed">34231395</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Clues to long COVID. Science. 2022;376:1261-1265.</Citation><ArticleIdList><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Grach SL, Ghosh AK, et al.. The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin Proc. 2022;97:454-464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller MR, Ganesh R, Hurt RT, Beckman TJ. Post-COVID conditions. Mayo Clin Proc. 2023;98:1071-1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">37419575</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al.. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706-1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundi MS, Patel JJ, Mohamed Elfadil O, et al.. When pandemics collide: the interplay of obesity and COVID-19. Curr Gastroenterol Rep. 2021;23:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8566966</ArticleId><ArticleId IdType="pubmed">34735631</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of National Statisctics. Updated Estimates of the Prevalence of Long COVID Symptoms. Office of National Statisctics; 2021.</Citation></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, et al.. Long COVID and significant activity limitation among adults, by age - United States, June 1-13, 2022, to June 7-19, 2023. MMWR Morb Mortal Wkly Rep. 2023;72:866-870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, et al.. True prevalence of long-COVID in a nationwide, population cohort study. Nat Commun. 2023;14:7892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10689486</ArticleId><ArticleId IdType="pubmed">38036541</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach K. New Data Shows Long Covid is Keeping as Many as 4 Million People Out of Work. Brookings Institution; 2022:24.</Citation></Reference><Reference><Citation>Taboada M, Carinena A, Moreno E, et al.. Post-COVID-19 functional status six-months after hospitalization. J Infect. 2021;82:e31-e33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Peluso MJ, Rodgers K, et al.. Therapeutic trials for long COVID-19: a call to action from the interventions taskforce of the RECOVER initiative. Front Immunol. 2023;14:1129459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10034329</ArticleId><ArticleId IdType="pubmed">36969241</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierle DM, Aakre CA, Grach SL, et al.. Central sensitization phenotypes in post acute sequelae of SARS-CoV-2 infection (PASC): defining the post COVID syndrome. J Prim Care Community Health. 2021;12:21501327211030826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267019</ArticleId><ArticleId IdType="pubmed">34231404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Vanichkachorn GS, Munipalli B, et al.. Postacute sequelae of SARS-CoV-2 infection-lessons learned from a coordinated health system response. Mayo Clin Proc Innov Qual Outcomes. 2022;6:311-319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9156955</ArticleId><ArticleId IdType="pubmed">35669936</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilman EA, Aakre C, Meyers A, et al.. Development of a visit facilitator role to assist physicians in an ambulatory consultative medical practice. Mayo Clin Proc Innov Qual Outcomes. 2023;7:187-193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10196913</ArticleId><ArticleId IdType="pubmed">37213712</ArticleId></ArticleIdList></Reference><Reference><Citation>Grach SL, Ganesh R, Messina SA, Hurt RT. Post-COVID-19 syndrome: persistent neuroimaging changes and symptoms 9 months after initial infection. BMJ Case Rep. 2022;15:e248448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8996041</ArticleId><ArticleId IdType="pubmed">35396239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurt RT, Edakkanambeth Varayil J, Epp LM, et al.. Blenderized tube feeding use in adult home enteral nutrition patients: a cross-sectional study. Nutr Clin Pract. 2015;30:824-829.</Citation><ArticleIdList><ArticleId IdType="pubmed">26150105</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu L, Tebe C, Loste C, et al.. Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. Lancet Reg Health Eur. 2023;33:100724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10636281</ArticleId><ArticleId IdType="pubmed">37954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, et al.. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13:5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli AM, Salonen BR, Ganesh R, et al.. Symptom presentation by phenotype of postural orthostatic tachycardia syndrome. Sci Rep. 2024;14:205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10761725</ArticleId><ArticleId IdType="pubmed">38168762</ArticleId></ArticleIdList></Reference><Reference><Citation>Grach SL, Seltzer J, Chon TY, Ganesh R. Diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome. Mayo Clin Proc. 2023;98:1544-1551.</Citation><ArticleIdList><ArticleId IdType="pubmed">37793728</ArticleId></ArticleIdList></Reference><Reference><Citation>Thilagar BP, Ghosh AK, Nguyen J, et al.. Anti-spike monoclonal antibody therapy in pregnant women with mild-to-moderate coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2022;139:616-618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8936149</ArticleId><ArticleId IdType="pubmed">35026789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Salonen BR, Bhuiyan MN, et al.. Managing patients in the COVID-19 pandemic: a virtual multidisciplinary approach. Mayo Clin Proc Innov Qual Outcomes. 2021;5:118-126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833108</ArticleId><ArticleId IdType="pubmed">33521583</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav S, Bonnes SL, Gilman EA, et al.. Inflammatory arthritis after COVID-19: a case series. Am J Case Rep. 2023;24:e939870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10311574</ArticleId><ArticleId IdType="pubmed">37368875</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey J, Lavelle B, Miller J, et al.. Multidisciplinary center care for long COVID syndrome: a retrospective cohort study. Am J Med. Published online May 22, 2023. doi:10.1016/j.amjmed.2023.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.05.002</ArticleId><ArticleId IdType="pmc">PMC10200714</ArticleId><ArticleId IdType="pubmed">37220832</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, et al.. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res. 2021;8:e001041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahamim-Cohen D, Kertes J, Feldblum I, Shamir-Stein N, Shapiro Ben David S. Use of a virtual multi-disciplinary clinic for the treatment of post-COVID-19 patients. Healthcare (Basel). 2024;12:376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10855243</ArticleId><ArticleId IdType="pubmed">38338261</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et al.. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329:1934-1946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittich CM, Burkle CM, Lanier WL. Ten common questions (and their answers) about off-label drug use. Mayo Clin Proc. 2012;87:982-990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538391</ArticleId><ArticleId IdType="pubmed">22877654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendra R, Hill A. Rethinking response rates: new evidence of little relationship between survey response rates and nonresponse bias. Eval Rev. 2019;43:307-330.</Citation><ArticleIdList><ArticleId IdType="pubmed">30580577</ArticleId></ArticleIdList></Reference><Reference><Citation>Sataloff RT, Vontela S. Response rates in survey research. J Voice. 2021;35:683-684.</Citation><ArticleIdList><ArticleId IdType="pubmed">33546940</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>